Pharmacy & Life Sciences
CROs, CDMOs, specialty pharmaceutical manufacturers, diagnostic labs, and pharmacy benefit managers supporting the drug development and distribution continuum.
- 8
- Segments
- 33
- Verticals
Overview
Pharmacy & Life Sciences spans the drug value chain — biopharmaceutical manufacturing, retail and specialty pharmacy, pharmacy benefit management, clinical research and contract manufacturing, laboratory and diagnostic services, and life-sciences services. It is one of the largest and most strategically important parts of healthcare.
Biopharma M&A is driven by patent cliffs and the GLP-1 boom; the PBM oligopoly is under intense regulatory and political scrutiny over drug pricing; retail pharmacy is consolidated and financially stressed; and CRO/CDMO outsourcing is booming with drug-development demand. Note that revenue overlaps across the chain — the same drug is counted at manufacturing, PBM, and retail stages — so segment figures are not additive.
Market snapshot
- Companies
- ~68,000
U.S. Census Bureau 2022 CBP/Economic Census across biopharma (325411/412/414, ~$211B), PBM (524292, ~$284B), retail pharmacy (456110, ~$544B), and labs (621511/991, ~$76B). Figures overlap across the value chain and are not summed; establishment count is additive.
Business model & economics
- Revenue model
- Drug sales, dispensing margin, benefit management, and services
- Recurring revenue
- High — recurring prescriptions and services
- EBITDA margin
- Varies widely — high for branded pharma, thin for pharmacy
- Capex intensity
- High
- Patent cliffs and GLP-1 drive biopharma M&A.
- PBM oligopoly under intense regulatory scrutiny.
- CRO/CDMO outsourcing booming with drug-development demand.
M&A deal context
Who’s acquiring
What’s driving deals
- Patent-cliff-driven biopharma acquisition.
- CRO/CDMO outsourcing consolidation.
- PBM and pharmacy vertical integration and scrutiny.
Segment classifications
- 4.9.1Biotech & Biopharmaceuticals5 verticals
- 4.9.2Clinical Research Organizations (CRO)4 verticals
- 4.9.3Contract Development & Manufacturing (CDMO)4 verticals
- 4.9.4Drug Delivery & Specialty Pharma4 verticals
- 4.9.5Laboratory & Diagnostic Services4 verticals
- 4.9.6Life Sciences Consulting & Advisory4 verticals
- 4.9.7Pharmacy Benefits Management (PBM)4 verticals
- 4.9.8Retail & Specialty Pharmacy4 verticals
Find Pharmacy & Life Sciences acquisition targets
Search Acquisera’s index for companies classified under Pharmacy & Life Sciences (4.9) and build a targeted deal pipeline.
Search companies